Zydus Lifesciences Ltd Quarterly Results

Gross Sales

6,290.2

5,123.5

5,113.6

6,046.5

5,366.4

Excise Duty

0

0

0

0

0

Net Sales

6,290.2

5,123.5

5,113.6

6,046.5

5,366.4

Other Operating Income

237.7

145.6

123.4

161

167.4

Other Income

80.6

57.5

68.5

63.2

159.6

Total Income

6,608.5

5,326.6

5,305.5

6,270.7

5,693.4

Total Expenditure

4,622

3,881.8

3,775.6

4,123.5

3,903.3

PBIDT

1,986.5

1,444.8

1,529.9

2,147.2

1,790.1

Interest

76.6

32

25.1

32.2

34.6

PBDT

1,909.9

1,412.8

1,504.8

2,115

1,755.5

Depreciation

237.9

229

233.6

215.3

205.3

Minority Interest Before NP

0

0

0

0

0

Tax

990.6

39.3

365.6

653.8

464.9

Deferred Tax

-567.4

140.2

7.5

-217.7

-143.7

Reported Profit After Tax

1,248.8

1,004.3

898.1

1,463.6

1,229

Minority Interest After NP

72.8

2.7

9

62.6

63.8

Net Profit after Minority Interest

1,170.9

1,023.5

911.2

1,419.9

1,182.3

Extra-ordinary Items

-89.49

-0.3

0.3

0

3.2

Adjusted Profit After Extra-ordinary item

1,260.39

1,023.8

910.9

1,419.9

1,179.1

EPS (Unit Curr.)

11.64

10.17

9.06

14.11

11.69

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

100.6

100.6

100.6

100.6

100.6

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.58

28.19

29.91

35.51

33.35

PBDTM(%)

30.36

27.57

29.42

34.97

32.71

PATM(%)

19.85

19.6

17.56

24.2

22.9